A systematic review on the epidemiological data of erythema nodosum leprosum, a type 2 leprosy reaction.
<h4>Background</h4>Erythema Nodosum Leprosum (ENL) is a humoral immunological response in leprosy that leads to inflammatory skin nodules which may result in nerve and organ damage, and may occur years after antibiotic treatment. Multiple episodes are frequent and suppression requires hi...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Series: | PLoS Neglected Tropical Diseases |
| Online Access: | https://doi.org/10.1371/journal.pntd.0002440 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849321016662163456 |
|---|---|
| author | Carlijn G N Voorend Erik B Post |
| author_facet | Carlijn G N Voorend Erik B Post |
| author_sort | Carlijn G N Voorend |
| collection | DOAJ |
| description | <h4>Background</h4>Erythema Nodosum Leprosum (ENL) is a humoral immunological response in leprosy that leads to inflammatory skin nodules which may result in nerve and organ damage, and may occur years after antibiotic treatment. Multiple episodes are frequent and suppression requires high doses of immunosuppressive drugs. Global occurrence is unknown.<h4>Methodology/principal findings</h4>Systematic review of evidence on ENL incidence resulted in 65 papers, predominantly from India (24) and Brazil (9), and inclusive of four reviews. Average incidences are based on cumulative incidence and size of study populations (n>100). In field-based studies 653/54,737 (1.2%) of all leprosy cases, 194/4,279 (4.5%) of MB cases, and 86/560 (15.4%) of LL cases develop ENL. Some studies found a range of 1-8 per 100 person-years-at-risk (PYAR) amongst MB cases. Hospital samples indicate that 2,393/17,513 (13.7%) of MB cases develop ENL. Regional differences could not be confirmed. Multiple ENL episodes occurred in 39 to 77% of ENL patients, with an average of 2.6. Some studies find a peak in ENL incidence in the first year of treatment, others during the second and third year after starting MDT. The main risk factor for ENL is a high bacteriological index.<h4>Conclusions/significance</h4>Few studies reported on ENL as a primary outcome, and definitions of ENL differed between studies. Although, in this review averages are presented, accurate data on global and regional ENL incidence is lacking. Large prospective studies or accurate surveillance data would be required to clarify this. Health staff needs to be aware of late reactions, as new ENL may develop as late as five years after MDT completion, and recurrences up to 8 years afterwards. |
| format | Article |
| id | doaj-art-96f10e9927a64c5c916c6b58ef346e43 |
| institution | Kabale University |
| issn | 1935-2727 1935-2735 |
| language | English |
| publishDate | 2013-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS Neglected Tropical Diseases |
| spelling | doaj-art-96f10e9927a64c5c916c6b58ef346e432025-08-20T03:49:54ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352013-01-01710e244010.1371/journal.pntd.0002440A systematic review on the epidemiological data of erythema nodosum leprosum, a type 2 leprosy reaction.Carlijn G N VoorendErik B Post<h4>Background</h4>Erythema Nodosum Leprosum (ENL) is a humoral immunological response in leprosy that leads to inflammatory skin nodules which may result in nerve and organ damage, and may occur years after antibiotic treatment. Multiple episodes are frequent and suppression requires high doses of immunosuppressive drugs. Global occurrence is unknown.<h4>Methodology/principal findings</h4>Systematic review of evidence on ENL incidence resulted in 65 papers, predominantly from India (24) and Brazil (9), and inclusive of four reviews. Average incidences are based on cumulative incidence and size of study populations (n>100). In field-based studies 653/54,737 (1.2%) of all leprosy cases, 194/4,279 (4.5%) of MB cases, and 86/560 (15.4%) of LL cases develop ENL. Some studies found a range of 1-8 per 100 person-years-at-risk (PYAR) amongst MB cases. Hospital samples indicate that 2,393/17,513 (13.7%) of MB cases develop ENL. Regional differences could not be confirmed. Multiple ENL episodes occurred in 39 to 77% of ENL patients, with an average of 2.6. Some studies find a peak in ENL incidence in the first year of treatment, others during the second and third year after starting MDT. The main risk factor for ENL is a high bacteriological index.<h4>Conclusions/significance</h4>Few studies reported on ENL as a primary outcome, and definitions of ENL differed between studies. Although, in this review averages are presented, accurate data on global and regional ENL incidence is lacking. Large prospective studies or accurate surveillance data would be required to clarify this. Health staff needs to be aware of late reactions, as new ENL may develop as late as five years after MDT completion, and recurrences up to 8 years afterwards.https://doi.org/10.1371/journal.pntd.0002440 |
| spellingShingle | Carlijn G N Voorend Erik B Post A systematic review on the epidemiological data of erythema nodosum leprosum, a type 2 leprosy reaction. PLoS Neglected Tropical Diseases |
| title | A systematic review on the epidemiological data of erythema nodosum leprosum, a type 2 leprosy reaction. |
| title_full | A systematic review on the epidemiological data of erythema nodosum leprosum, a type 2 leprosy reaction. |
| title_fullStr | A systematic review on the epidemiological data of erythema nodosum leprosum, a type 2 leprosy reaction. |
| title_full_unstemmed | A systematic review on the epidemiological data of erythema nodosum leprosum, a type 2 leprosy reaction. |
| title_short | A systematic review on the epidemiological data of erythema nodosum leprosum, a type 2 leprosy reaction. |
| title_sort | systematic review on the epidemiological data of erythema nodosum leprosum a type 2 leprosy reaction |
| url | https://doi.org/10.1371/journal.pntd.0002440 |
| work_keys_str_mv | AT carlijngnvoorend asystematicreviewontheepidemiologicaldataoferythemanodosumleprosumatype2leprosyreaction AT erikbpost asystematicreviewontheepidemiologicaldataoferythemanodosumleprosumatype2leprosyreaction AT carlijngnvoorend systematicreviewontheepidemiologicaldataoferythemanodosumleprosumatype2leprosyreaction AT erikbpost systematicreviewontheepidemiologicaldataoferythemanodosumleprosumatype2leprosyreaction |